Serum soluble interleukin-2 receptor (sIL-2R) is considered a marker of lymphocyte (T and B cell)-mediated immune activation, and elevated levels have been recognised as a biomarker for malignant lymphoma, such as non-Hodgkin’s lymphoma and adult T-cell leukaemia/lymphoma. Serum sIL-2R levels are commonly measured to evaluate the disease state and therapeutic effect, and to detect recurrence in patients with malignant lymphoma in daily practice.
References:
Murakami, Jun et al. “Serum soluble interleukin-2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions.” Molecular and clinical oncology vol. 11,5 (2019): 474-482. doi:10.3892/mco.2019.1922
Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 1990 Oct 15;113(8):619-27. doi: 10.7326/0003-4819-113-8-619. PMID: 2205142.
N Yasuda, PK Lai, SH Ip, PC Kung, Y Hinuma, M Matsuoka, T Hattori, K Takatsuki, DT Purtilo; Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71 (4): 1021–1026. doi: https://doi.org/10.1182/blood.V71.4.1021.1021
Wagner DK, Kiwanuka J, Edwards BK, Rubin LA, Nelson DL, Magrath IT. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol. 1987 Aug;5(8):1262-74. doi: 10.1200/JCO.1987.5.8.1262. PMID: 3114436.
Chrobák L. Clinical significance of soluble interleukin-2 receptor. Acta Medica (Hradec Kralove). 1996;39(1):3-6 (review). PubMed 9106384
Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells. 1991 Dec;3(12):471-479. PubMed 1820093
Bodey B, Psenko V, Lipsey AL, Kaiser HE. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Anticancer Res. 1996 Jan-Feb;16(1):219-224. PubMed 8615612
Wagstaff J, Baars JW, Wolbink GJ, Hoekman K, Eerenberg-Belmer AJ, Hack CE. Renal cell carcinoma and interleukin-2: A review. Eur J Cancer. 1995;31A(3):401-408 (review). PubMed 7540404
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.